Microtubule inhibition therapy by colchicine in severe myocarditis especially caused by epstein-barr and cytomegalovirus co-infection during a two-year period: A novel therapeutic approach

Journal of the Pakistan Medical Association

Volumn 64, Issue 12, 2014, Pages 1420-1423

  Gultekin, Nazmi ^a   Kucukates, Emine ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Colchicine; Epstein Barr virus Cytomegalovirus coinfection; Myocarditis

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; COLCHICINE; FUROSEMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METOPROLOL; TUBULIN MODULATOR;

ADJUVANT THERAPY; ADULT; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEVER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART PALPITATION; HEPATOMEGALY; HUMAN; LOW DRUG DOSE; M MODE ECHOCARDIOGRAPHY; MALE; MIDDLE AGED; MITOSIS INHIBITION; MIXED INFECTION; RESPIRATORY TRACT INFECTION; THORAX PAIN; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VIRUS MYOCARDITIS; CASE REPORT; COINFECTION; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; ECHOGRAPHY; EPSTEIN-BARR VIRUS INFECTIONS; MICROBIOLOGY; MYOCARDITIS; PATHOPHYSIOLOGY;

ADULT; COINFECTION; COLCHICINE; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; TUBULIN MODULATORS;

EID: 84928336765     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mocarski ES, Shenk T, Pass R. Cytomegaloviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Vol II. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007; pp 2701-72.
2. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-92.
3. Wang X, Yang K, Wei C, Huang Y, Zhao D. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis. J Virol 2010; 7: 1-10.
4. Liu PP, Schultheiss HP. Myocarditis. In: Braunwald Heart Disease-A textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Saunders, An Imprint of Elsevier; 2011; 1602-6.
5. Schulteis HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J 2011; 32: 2616-25.
6. Schauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R. Acute viral myocarditis: current concepts in diagnosis and treatment. IMAJ 2013; 15: 180-5.
7. Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, et al, Colchicine and heart. JACC 2013; 62: 1817-24.
8. Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155: 409-14.
9. Imazio M, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, et al, Colchicine prevents early postoperative pericardial and pleural effusions. Am Heart J 2011; 162: 527-32.
10. Gultekin N, Kucukates E. An unusual form of Naxos Disease and its improvement by adjuvant low-dose colchicine therapy. Acta Cardiol 2013; 68: 433-7.
11. Balasubramanian E, Gajendran T. Comparative studies on the anticancer activity of colchicine by various controlled drug delivery modes. Int J Pharm Bio Sci 2013; 4: 9-26.
12. Lu Y, Chen J, Xiao M, Li W, Miller DD. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 2012; 29: 2943-71.
13. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cellbased therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011; 32: 1197-206.
14. Ray CG, Icenogle TB, Minnch LL, Copeland JG, Grogan TM. The use of intravenous ribavirin to treat influenzae virus-associatedacute myocarditis. J Infect Dis 1989; 159: 829-36.
15. Garnham CP, Rol-Mecak A. The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions. Cytoskeleton 2012; 69: 442-63